Literature DB >> 3016292

Further characterization of the vesicular stomatitis virus temperature-sensitive O45 mutant: intracellular conversion of the glycoprotein to a soluble form.

S S Chen, A S Huang.   

Abstract

Reexamination of the viral products of tsO45, a glycoprotein mutant of vesicular stomatitis virus, showed that at 39 degrees C there was a conversion of the glycoprotein (G) to a truncated, soluble form, Gs, which subsequently appeared in the extracellular medium. The half-life for this intracellular conversion and extracellular appearance was about 2 h at 39 degrees C. Gs was precipitated by a monoclonal antibody to the ektodomain but not by an antipeptide serum made against the first 15 amino acids at the carboxy terminus of G. Gs was also resistant to endoglycosidase H digestion. On the basis of pulse-chase experiments, the generation of Gs most probably occurred in the rough endoplasmic reticulum. This additional phenotype of the tsO45 mutant provides another approach for studying the generation and subsequent transport of a secreted protein in fibroblast cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016292      PMCID: PMC253068     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Maturation of viral proteins in cells infected with temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  D M Knipe; D Baltimore; H F Lodish
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

2.  Analysis of the defects of temperature-sensitive mutants of vesicular stomatitis virus: intracellular degradation of specific viral proteins.

Authors:  D Knipe; H F Lodish; D Baltimore
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

3.  A single amino acid substitution in a hydrophobic domain causes temperature-sensitive cell-surface transport of a mutant viral glycoprotein.

Authors:  C J Gallione; J K Rose
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Proteins of vesicular stomatitis virus. 3. Intracellular synthesis and extracellular appearance of virus-specific proteins.

Authors:  C Y Kang; L Prevec
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

5.  Envelope proteins of vesicular stomatitis virus: effect of temperature-sensitive mutations in complementation groups III and V.

Authors:  F Lafay
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

6.  The homologies of spontaneous and induced temperature-sensitive mutants of vesicular stomatitis virus isolated in chick embryo and BHK 21 cells.

Authors:  A Flamand; C R Pringle
Journal:  J Gen Virol       Date:  1971-05       Impact factor: 3.891

7.  The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody.

Authors:  J M Kelley; S U Emerson; R R Wagner
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

8.  Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus.

Authors:  A L Tarentino; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

9.  Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles.

Authors:  M Stampfer; D Baltimore; A S Huang
Journal:  J Virol       Date:  1969-08       Impact factor: 5.103

10.  Comparison of membrane protein glycopeptides of Sindbis virus and vesicular stomatitis virus.

Authors:  B W Burge; A S Huang
Journal:  J Virol       Date:  1970-08       Impact factor: 5.103

View more
  11 in total

Review 1.  The glycoprotein G of rhabdoviruses.

Authors:  J M Coll
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

2.  The soluble viral glycoprotein of vesicular stomatitis virus efficiently sensitizes target cells for lysis by CD4+ T lymphocytes.

Authors:  M Browning; C S Reiss; A S Huang
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

Review 3.  [Imaging of oligometastatic disease in selected urologic cancers].

Authors:  S A Koerber; C A Fink; K Dendl; D Schmitt; G Niegisch; E Mamlins; F L Giesel
Journal:  Urologe A       Date:  2021-11-30       Impact factor: 0.639

4.  Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein.

Authors:  S S Chen; C N Lee; W R Lee; K McIntosh; T H Lee
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Membrane anchors of vesicular stomatitis virus: characterization and incorporation into virions.

Authors:  S S Chen; N Ariel; A S Huang
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

6.  Formation of heterotrimers between the membrane-integrated and the soluble glycoproteins of vesicular stomatitis virus leads to their intracellular cotransport.

Authors:  C Schmidt; J Grünberg; J Kruppa
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Eeyarestatin 1 interferes with both retrograde and anterograde intracellular trafficking pathways.

Authors:  Mina-Olga Aletrari; Craig McKibbin; Helen Williams; Vidya Pawar; Paola Pietroni; J Michael Lord; Sabine L Flitsch; Roger Whitehead; Eileithyia Swanton; Stephen High; Robert A Spooner
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

8.  Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus.

Authors:  C Hammond; A Helenius
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

9.  Intracellular degradation of unassembled asialoglycoprotein receptor subunits: a pre-Golgi, nonlysosomal endoproteolytic cleavage.

Authors:  J F Amara; G Lederkremer; H F Lodish
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

10.  Nonlysosomal, pre-Golgi degradation of unassembled asialoglycoprotein receptor subunits: a TLCK- and TPCK-sensitive cleavage within the ER.

Authors:  L Wikström; H F Lodish
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.